Richard Lafayette, MD, FACP, is professor of medicine, nephrology, and director, Glomerular Disease Center, Stanford University Medical Center, and Vanrafia ALIGN study investigator and steering committee member.
New Hope for IgA Nephropathy With Atrasentan Approval: Richard Lafayette, MD, FACP
Richard Lafayette, MD, FACP, Stanford University Medical Center, explains the significance of this second approval in a month for proteinuria reduction.